Skip to content

Evaluation of Vitamin A and Zinc Supplementation on Malarial Morbidity

Evaluation of the Impact of Vitamin A and Zinc Supplementation on Malarial Morbidity in Ghana

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01782001
Enrollment
200
Registered
2013-02-01
Start date
2009-03-31
Completion date
2009-11-30
Last updated
2013-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria, Malnutrition

Keywords

Vitamin A, Zinc, Malaria, Morbidity, MRDR

Brief summary

The purpose of this study was to determine whether young children receiving Vitamin A and Zinc supplements will have a lower incidence of symptomatic malaria than similar children receiving vitamin A supplements alone.

Detailed description

The aim of our study was to determine the impact of the combination of vitamin A and zinc supplements on malaria morbidity in young children. The primary objective was to determine the effect of vitamin A alone vs. vitamin A and zinc supplements on the incidence of clinical malaria. The specific objectives were to determine the effect of vitamin A alone vs. vitamin A and zinc supplements on changes in anthropometric measurements specifically weight and length/height and to assess the effect of the study interventions on the incidence of anemia, diarrhea and pneumonia. It also assessed the tolerability of the supplements and determined the change in zinc status by measuring plasma zinc concentration using atomic absorption spectrometry before and at the end of the intervention. The study also determined the change in vitamin A status as assessed by the modified relative dose response (MRDR) test during and at the end of the intervention.

Interventions

DIETARY_SUPPLEMENTvitamin A

vitamin A with placebo

DIETARY_SUPPLEMENTvitamin A and zinc

combination of vitamin A and zinc supplements

Sponsors

International Atomic Energy Agency
CollaboratorOTHER_GOV
University of Wisconsin, Madison
CollaboratorOTHER
Kintampo Health Research Centre, Ghana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Children aged 6 - 24 months * Child's guardian is willing to provide informed consent * Child's family plans to remain resident in the study areas during the study period

Exclusion criteria

* Clinical evidence of vitamin A deficiency * Severe acute malnutrition * Severe illness * Child aged \<6 months or \>24 months * Receipt of vitamin A supplement within the last three months

Design outcomes

Primary

MeasureTime frame
incidence of clinical malaria attacks6 months

Secondary

MeasureTime frameDescription
changes in weight and height/lengthbaseline and 6 monthsEnrollment and end of supplementation
changes in vitamin A and zinc nutritional status within and between the groupsbaseline and 6 monthsenrollment and end of supplementation
change in prevalence of anemiabaseline and 6 monthsenrollment and end of supplementation
the incidence of diarrhea and pneumonia1 time per week up to 6 months1 time/week, enrollment to end, total:24

Countries

Ghana

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026